Bank of Montreal’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,932
| Closed | -$169K | – | 5140 |
|
|
2019
Q3 | $169K | Sell |
8,932
-12,496
| -58% | -$143K | ﹤0.01% | 3009 |
|
|
2019
Q2 | $252K | Buy |
21,428
+6,089
| +40% | +$73.7K | ﹤0.01% | 2802 |
|
|
2019
Q1 | $209K | Sell |
15,339
-1,207
| -7% | -$15.6K | ﹤0.01% | 2699 |
|
|
2018
Q4 | $169K | Buy |
16,546
+423
| +3% | +$5.42K | ﹤0.01% | 2675 |
|
|
2018
Q3 | $269K | Sell |
16,123
-8
| -0% | -$145 | ﹤0.01% | 2608 |
|
|
2018
Q2 | $255K | Buy |
16,131
+414
| +3% | +$6.29K | ﹤0.01% | 2648 |
|
|
2018
Q1 | $200K | Sell |
15,717
-21,164
| -57% | -$306K | ﹤0.01% | 2636 |
|
|
2017
Q4 | $422K | Buy |
36,881
+17,376
| +89% | +$194K | ﹤0.01% | 2365 |
|
|
2017
Q3 | $239K | Buy |
19,505
+15,362
| +371% | +$160K | ﹤0.01% | 2598 |
|
|
2017
Q2 | $47K | Sell |
4,143
-1,459
| -26% | -$27K | ﹤0.01% | 3247 |
|
|
2017
Q1 | $117K | Buy |
5,602
+5,424
| +3,047% | +$120K | ﹤0.01% | 2745 |
|
|
2016
Q4 | $4K | Hold |
178
| – | – | ﹤0.01% | 3798 |
|
|
2016
Q3 | $6K | Hold |
178
| – | – | ﹤0.01% | 3681 |
|
|
2016
Q2 | $4K | Sell |
178
-146
| -45% | -$3.95K | ﹤0.01% | 3811 |
|
|
2016
Q1 | $8K | Buy |
324
+114
| +54% | +$2.64K | ﹤0.01% | 3692 |
|
|
2015
Q4 | $7K | Hold |
210
| – | – | ﹤0.01% | 3726 |
|
|
2015
Q3 | $7K | Buy |
+210
| New | +$8.93K | ﹤0.01% | 3584 |
|
Bank of Montreal's ALDR Position: Q4 2019 in Review
Bank of Montreal sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 8,932 shares — an estimated $169K sold.
Bank of Montreal first reported a position in ALDR in Q3 2015 and held it in 17 quarters. The position peaked at $422K in Q4 2017. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Bank of Montreal reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Bank of Montreal sold 8,932 Alder Biopharmaceuticals shares in Q4 2019, an estimated $169K.
- Bank of Montreal first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 17 quarters.
- Bank of Montreal's Alder Biopharmaceuticals position peaked at $422K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.